Rejuvenation Dermatology offers sponsors a fully integrated, multi-site clinical trials network across Canada, designed to deliver efficient study execution and high-quality data at scale. With coordinated infrastructure and centralized oversight, we enable streamlined study start-up, access to diverse patient populations, and scalable enrollment across multiple regions.
Each site is equipped with dedicated research facilities and experienced clinical trial teams, supported by standardized systems for regulatory submissions, data collection, and quality control. Our operations are built to ensure consistency, audit readiness, and seamless collaboration at every stage of the study.
With experience across all trial phases, from early safety studies to post-marketing research, Rejuvenation Dermatology is a trusted partner for sponsors seeking reliable execution, regulatory compliance, and data integrity in advancing dermatologic innovation.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
Rejuvenation Dermatology operates as a coordinated multi-site research network across Canada. This structure enables streamlined study activation, access to diverse patient populations, and scalable enrollment across multiple regions.
Each research site features a dedicated clinical trial space and trained research staff. Operations are supported by centralized systems for regulatory submissions, data collection, and quality control. The division also leverages digital platforms for secure data capture and management, ensuring data integrity, audit readiness, and seamless collaboration with sponsors.
Rejuvenation Dermatology implements multiple layers of quality control, including internal peer review of data entry, centralized oversight, and sponsor monitoring. Standardized training ensures consistent protocol adherence across all sites.
All studies are conducted in an audit ready environment, fully compliant withHealth Canada regulations, Good Clinical Practice standards, and sponsor requirements.
The Clinical Trials Division has experience conducting studies across all phases, including:
Phase I safety studies
Phase II dose finding and efficacy trials
Phase III confirmatory trials
Phase IV post marketing observational studies
SPONSORS | CLINICAL TRIALS | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
